Ligand-mediated highly effective and selective C-N coupling for synthesizing bioactive N-aryltriazole acyclonucleosides
- PMID: 21086980
- DOI: 10.1021/ol102537p
Ligand-mediated highly effective and selective C-N coupling for synthesizing bioactive N-aryltriazole acyclonucleosides
Abstract
N-aryltriazole nucleosides are new chemical entities with potential biological activity. The two phosphor ligands, Synphos and Xantphos, had a selective and effective impact on Pd-catalyzed C-N coupling with the 5- and 3-bromotriazole acyclonucleoside isomers, affording the corresponding and otherwise difficult to achieve N-aryltriazole nucleosides with good to excellent yields. In addition, two of the synthesized nucleosides showed superior anticancer activity against drug-resistant pancreatic cancer, compared to the reference drug gemcitabine.
Similar articles
-
An efficient mixed-ligand Pd catalytic system to promote C-N coupling for the synthesis of N-arylaminotriazole nucleosides.Chemistry. 2012 Feb 20;18(8):2221-5. doi: 10.1002/chem.201103918. Epub 2012 Jan 20. Chemistry. 2012. PMID: 22266830
-
S-aryltriazole acyclonucleosides: synthesis and biological evaluation against hepatitis C virus.Bioorg Med Chem Lett. 2010 Jun 15;20(12):3610-3. doi: 10.1016/j.bmcl.2010.04.115. Epub 2010 Apr 28. Bioorg Med Chem Lett. 2010. PMID: 20483607
-
Pd-catalyzed oxidative C-H alkenylation for synthesizing arylvinyltriazole nucleosides.Org Biomol Chem. 2015 Jan 7;13(1):110-4. doi: 10.1039/c4ob01836b. Org Biomol Chem. 2015. PMID: 25338673
-
A beta-keto ester as a novel, efficient, and versatile ligand for copper(I)-catalyzed C-N, C-O, and C-S coupling reactions.J Org Chem. 2007 May 11;72(10):3863-7. doi: 10.1021/jo070443m. Epub 2007 Apr 14. J Org Chem. 2007. PMID: 17432916
-
Cu-catalyzed azide-alkyne cycloaddition.Chem Rev. 2008 Aug;108(8):2952-3015. doi: 10.1021/cr0783479. Chem Rev. 2008. PMID: 18698735 Review. No abstract available.
Cited by
-
E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments.Sci Rep. 2018 May 29;8(1):8330. doi: 10.1038/s41598-018-26613-z. Sci Rep. 2018. PMID: 29844366 Free PMC article.
-
Advance of structural modification of nucleosides scaffold.Eur J Med Chem. 2021 Mar 15;214:113233. doi: 10.1016/j.ejmech.2021.113233. Epub 2021 Jan 30. Eur J Med Chem. 2021. PMID: 33550179 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources